<DOC>
	<DOCNO>NCT00392262</DOCNO>
	<brief_summary>The purpose study evaluate efficacy valsartan plus amlodipine hypertensive patient respond treatment amlodipine felodipine alone .</brief_summary>
	<brief_title>A Study Evaluate Combination Valsartan + Amlodipine Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Male female patient ( 18 year ) 2 . Patients moderate essential hypertension ( untreated must MSSBP ≥160 &lt; 180 mmHg Visit 1 , treat must MSSBP &lt; 180 mmHg Visit 1 ) ( WHO grade II ) 1 . Severe hypertension ( MSDBP ≥110 mmHg MSSBP ≥ 180 mmHg ) 2 . Pregnant nursing woman 3 . Treated hypertensive patient control hypertension current therapy ( diastolic BP &lt; 90 mmHg systolic BP &lt; 140 mmHg ) 4 . A history cardiovascular disease , include angina pectoris , myocardial infarction , coronary artery bypass graft , percutaneous transluminal coronary angioplasty , transient ischemic attack , stroke , heart failure NYHA II IV Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Moderate essential hypertension ( WHO grade II )</keyword>
</DOC>